The vivo X200 Pro may emerge as the camera phone to beat in 2025. What else does the flagship have going for it?

The first renders have surfaced thanks to a certification in China. vivo launched the X200, X200 Pro, and X200 Pro mini in ...

BRISBANE, Calif., January 08, 2025 -- ( BUSINESS WIRE )-- Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene-editing platform to create potential ...

While the OnePlus 13 is a worthy contender in the flagship smartphone market, its competition remains fierce. For those ...

The mid-range smartphone market in 2025 is packed with feature-rich devices, offering high-end specifications at competitive ...

From massive sensors that rival dedicated cameras to improved periscope systems enabling incredible zoom capabilities, the ...

Here's a curated list of the best smartphones you can buy in India for under Rs 35,000 this January. Listen to Story Redmi ...

Dixon Technologies shares fell 8% to ₹16,982, marking the worst drop in over two months. Despite a 175% increase in CY24, Nomura raised its target price to ₹22,256 apiece, maintaining its ’buy’ ...

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and ...

Big tech companies want you to know they're working on XR, but don't have anything for you to buy. You shouldn't fall for it.

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle cell and beta thalassemia.